• 1
    Clavien PA, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: overview and synthesis of current studies. Transplantation 1992; 53: 957978.
  • 2
    Strasberg SM. Preservation injury and donor selection: it all starts here. Liver Transplant Surg 1997; 3: S1S7.
  • 3
    Starzl TE, Demetris AJ. Liver transplantation: a 31-year perspective. Part I+II. Curr Probl Surg 1990; 27: 49178.
  • 4
    Plevak DJ, Findlay JY. Critical care issues in liver transplantation. Liver Transpl 2000; 6: S2S4.
  • 5
    Cattral MS, Lilly LB, Levy GA. Immunosuppression in liver transplantation. Semin Liver Dis 2000; 20: 523531.
  • 6
    Consensus Conference on indications of liver transplantation. Hepatology 1994; 20: 1S68S.
  • 7
    Neuberger J. Liver transplantation. J Hepatol 2000; 32 (Suppl 1): 198207.
  • 8
    Strong RW. Liver transplantation: current status and future prospects. JR Coll Surg Edinb 2001; 46: 18.
  • 9
    Strasberg SM, Howard TK, Molmenti EP, Hertl M. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829838.
  • 10
    Jaeschke H. Preservation injury. mechanisms, prevention and consequences. J Hepatol 1996; 25: 774780.
  • 11
    Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327338.
  • 12
    Serracino-Inglott F, Habib NA, Mathie RT. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160166.
  • 13
    Boudjema KS, Lindell SL, Southard JH, Belzer FO. The effects of fasting on the quality of liver preservation by simple cold storage. Transplantation 1990; 50: 943948.
  • 14
    Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000; 32: 508515.
  • 15
    Mora NP, Gonwa TA, Goldstein RM, Husberg BS, Klintmalm GB. Risk of perioperative infection after liver transplantation: a univariate and stepwise logistic regression analysis of risk factors in 150 consecutive patients. Clin Transplantation 1992; 46: 443449.
  • 16
    Platz KP, Mueller AR, Blumhardt G et al. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994; 58: 170178.
  • 17
    Deschenes M, Belle SH, Krom RA, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation. a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66: 302310.
  • 18
    Glanemann M, Kaisers U, Langrehr JM et al. Incidence and indications for reintubation during postoperative care following orthotopic liver transplantation. J Clin Anesth 2001; 13: 377382.
  • 19
    Neuhaus P, Blumhardt G, Bechstein WO et al. Comparison of FK506- and Cyclosporine-based immunosuppression in primary orthotopic liver transplantation. Transplantation 1995; 59: 3140.
  • 20
    Neuhaus P, Bechstein WO, Lefebre B, Blumhardt G, Slama K. Effect of aprotinin on intraoperative bleeding and fibrinolysis in liver transplantation. Lancet 1989; 14: 924925.
  • 21
    Glanemann M, Langrehr JM, Kaisers U et al. Postoperative tracheal extubation after orthotopic liver transplantation. Acta Anaesthesiol Scand 2001; 45: 333339.
  • 22
    Bilbao I, Charco R, Hidalgo E et al. Risk factors for severe ischemic injury after liver transplantation. Transplant Proc 1997; 29: 368370.
  • 23
    Katz E, Mor E, Schwartz ME, Theise N, Patel T, Miller CM. Preservation injury in clinical liver transplantation. Incidence and effect on rejection and survival. Clin Transplantation 1994; 8: 492496.
  • 24
    Shackleton CR, Martin P, Melinek J et al. Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. Transplantation 1995; 60: 554558.
  • 25
    Bao YM, Adam R, Farges O et al. Impact of preservation-induced liver injury on the risk of rejection of rat and human liver grafts. Transplant Proc 1995; 27: 25022503.
  • 26
    Kiuchi T, Schlitt HJ, Oldhafer KJ et al. Early acute rejection after hepatic graft reperfusion. Association with ischemic injury with good function, oxygenation heterogeneity, and leukocyte adhesion without aggregation. Transplant Proc 1997; 29: 364365.
  • 27
    Shaked A, Nunes FA, Olthoff KM, Lucey MR. Assessment of liver function: pre- and peritransplant evaluation. Clin Chem 1997; 43: 15391545.
  • 28
    Howard TK, Klintmalm GB, Cofer JB, Husberg BS, Goldstein RM, Gonwa TA. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49: 103107.
  • 29
    Pirenne J, Gunson B, Khaleef H et al. Influence of ischemia-reperfusion injury on rejection after liver transplantation. Transplant Proc 1997; 29: 366367.
  • 30
    Mueller AR, Platz KP, Haak M et al. The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation. Transplantation 1996; 62: 11181126.
  • 31
    Sheron N, Eddleston A. Preservation-reperfusion injury, primary graft non-function and tumor necrosis factor. J Hepatol 1992; 16: 262265.
  • 32
    Lemasters JJ, Bunzendahl H, Thurman RG. Reperfusion injury to donor livers stored for transplantation. Liver Transplant Surg 1995; 1: 124138.
  • 33
    Bzeizi KI, Jalan R, Plevris JN, Hayes PC. Primary graft dysfunction after liver transplantation: from pathogenesis to prevention. Liver Transplant Surg 1997; 3: 137148.